NOVA SOUTHEASTERN UNIVERSITY
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 1964-01-01
- Employees
- 4.5K
- Market Cap
- -
- Website
- http://www.nova.edu
Clinical Trials
71
Trial Phases
5 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (61 trials with phase data)• Click on a phase to view related trials
The Effects of Gyngerlean Supplementation on Energy Expenditure
- Conditions
- No Disease or Condition is Being StudiedMetabolism
- First Posted Date
- 2025-02-03
- Last Posted Date
- 2025-02-03
- Lead Sponsor
- Nova Southeastern University
- Target Recruit Count
- 10
- Registration Number
- NCT06805201
- Locations
- 🇺🇸
Nova Southeastern University, Davie, Florida, United States
Mitigating Response to Stressors in Pregnant Women
- Conditions
- Pregnancy
- First Posted Date
- 2024-12-05
- Last Posted Date
- 2025-01-08
- Lead Sponsor
- Nova Southeastern University
- Target Recruit Count
- 50
- Registration Number
- NCT06718907
- Locations
- 🇺🇸
Nova Southeastern University, Davie, Florida, United States
Magnesium Supplementation on Body Composition
- Conditions
- Body Composition Changes
- First Posted Date
- 2024-11-25
- Last Posted Date
- 2025-06-06
- Lead Sponsor
- Nova Southeastern University
- Target Recruit Count
- 12
- Registration Number
- NCT06703099
- Locations
- 🇺🇸
Nova Southeastern University HPD Annex Building, Davie, Florida, United States
The Effectiveness of Guided Imagery on PCL-5 Scores in Adult Women With Post-Traumatic Stress Disorder
- Conditions
- Post Traumatic Stress Disorder PTSD
- First Posted Date
- 2024-11-01
- Last Posted Date
- 2025-04-13
- Lead Sponsor
- Nova Southeastern University
- Target Recruit Count
- 15
- Registration Number
- NCT06669442
- Locations
- 🇺🇸
Jessie Trice Community Health Systems, Miami, Florida, United States
Treatment of U.S. Veterans with Mild Traumatic Brain Injury with Hyperbaric Oxygen Therapy
- Conditions
- Mild Traumatic Brain InjuryHyperbaric Oxygen TherapyDepression
- Interventions
- Device: Hyperbaric Oxygen Therapy Chamber
- First Posted Date
- 2024-10-30
- Last Posted Date
- 2024-10-30
- Lead Sponsor
- Nova Southeastern University
- Target Recruit Count
- 40
- Registration Number
- NCT06665633
- Locations
- 🇺🇸
Nova Southeastern University, Fort Lauderdale, Florida, United States
- Prev
- 1
- 2
- 3
- 4
- 5
- 15
- Next
News
Global Clinical Trial Launches to Test Sipavibart as Potential Long COVID Treatment
Nova Southeastern University researchers have begun a clinical trial testing AstraZeneca's monoclonal antibody sipavibart as a potential treatment for Long COVID, funded by the Schmidt Initiative for Long COVID.